Thus, the results suggest that CLDN4 promoter DNA hypomethylation is the cause of CLDN4 overexpression in BUC, and that overexpression results in increased non-tight junction CLDN4, which promotes cancer stemness through integrin β1 activation and consequent increased malignant potential. This evidence concerns the gene CLDN4 and cancer.